Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/65263C95FA5E8FA2297A10C88F185EA5770BA7CACFF3C925E85053109AC6CC3FC886CDD5F84E70EE986B83F134C619B0http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/65263C95FA5E8FA2297A10C88F185EA5770BA7CACFF3C925E85053109AC6CC3FC886CDD5F84E70EE986B83F134C619B0http://www.w3.org/2000/01/rdf-schema#comment"e developed GPR142 agonists as insulin secretagogues. In this report we show the discovery of a selective potent small-molecule GPR142 antagonist CLP-3094 and its pharmacological characteristics. These data support targeting this receptor for the treatment of chronic inflammatory diseases."xsd:string
http://purl.uniprot.org/uniprot/#_3DDFF8CCED5AB096E9AF602E5667789A2B479C6DDBBEFC99A8A74351A375DA619329829898528DED528365647844EA9Fhttp://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/65263C95FA5E8FA2297A10C88F185EA5770BA7CACFF3C925E85053109AC6CC3FC886CDD5F84E70EE986B83F134C619B0
http://purl.uniprot.org/uniprot/Q7Z601http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/65263C95FA5E8FA2297A10C88F185EA5770BA7CACFF3C925E85053109AC6CC3FC886CDD5F84E70EE986B83F134C619B0
http://purl.uniprot.org/uniprot/#_Q7Z601-mappedCitation-27807998http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/65263C95FA5E8FA2297A10C88F185EA5770BA7CACFF3C925E85053109AC6CC3FC886CDD5F84E70EE986B83F134C619B0